Decloxizine-d8 Dihydrochloride

• CAT Number: R049458
• CAS Number: 1329836-11-4
• Molecular Formula: C21H28N2O2
• Molecular Weight: 348.516
• Purity: ≥95%
• Synonyms: 2-[2-[4-(Diphenylmethyl)-1-(piperazinyl-d8)]ethoxy]ethanol Hydrochloride; 1-[2-(2-Hydroxyethoxy)ethyl]-4-α-phenylbenzyldiethylenediamine-d8 Dihydrochloride; Autokar-d8; Hydroxydiethylphenamine-d8; Rescupal-d8; UCB 1402-d8
• Storage: -20°C
• IUPAC Name: 2-[2-(4-benzhydryl-2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)ethoxy]ethanol
• InChI: InChI=1S/C21H28N2O2/c24-16-18-25-17-15-22-11-13-23(14-12-22)21(19-7-3-1-4-8-19)20-9-5-2-6-10-20/h1-10,21,24H,11-18H2/i11D2,12D2,13D2,14D2
• InChIKey: OXBBIHZWNDPBMQ-FUEQIQQISA-N
• SMILES: C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=CC=C3

Decloxizine-d8 Dihydrochloride is a deuterated version of decloxizine, an antihistamine drug, where eight hydrogen atoms are replaced with deuterium. This compound is primarily used in pharmacokinetic and pharmacological studies as an internal standard in mass spectrometry. The deuterium labeling allows for precise differentiation from the non-labeled drug, facilitating accurate measurement and tracking in biological samples. Decloxizine-d8 Dihydrochloride is particularly valuable in pharmaceutical research for investigating the absorption, distribution, metabolism, and excretion (ADME) of decloxizine, aiding in the development and evaluation of antihistamine therapies.